Samreen Falak

Samreen Falak

Auto-generated profile, based on publicly available information

Samreen Falak

Physikalisch Technische Bundesanstalt, Abbestr. 2-12, 10587 Berlin, Germany

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LVLaura Vierbaum
Laura Vierbaum
NWNathalie Wojtalewicz
Nathalie Wojtalewicz
HGHans-Peter Grunert
Hans-Peter Grunert
VLVanessa Lindig
Vanessa Lindig
UDUlf Duehring
Ulf Duehring
MKMartin Kammel
Martin Kammel
SARS-CoV-2, the cause of COVID-19, requires reliable diagnostic methods to track the circulation of this virus. Following the development of RT-qPCR methods to meet this diagnostic need in January 2020, it became clear from interlaboratory studies that the reported Ct values obtained for the different laboratories showed high variability. Despite this the Ct values were explored as a quantitative cut off to aid clinical decisions based on viral load. Consequently, there was a need to introduce standards to support estimation of SARS-CoV-2 viral load in diagnostic specimens. In a collaborative study, INSTAND established two reference materials (RMs) containing heat-inactivated SARS-CoV-2 with SARS-CoV-2 RNA loads of ~107 copies/mL (RM 1) and ~106 copies/mL (RM 2), respectively. Quantification was performed by RT-qPCR using synthetic SARS-CoV-2 RNA standards and digital PCR. Between November 2020 and February 2021, German laboratories were invited to use the two RMs to anchor their Ct values measured in routine diagnostic specimens, with the Ct values of the two RMs. A total of 305 laboratories in Germany were supplied with RM 1 and RM 2. The laboratories were requested to report their measured Ct values together with details on the PCR method they used to INSTAND. This resultant 1,109 data sets were differentiated by test system and targeted gene region. Our findings demonstrate that an indispensable prerequisite for linking Ct values to SARS-CoV-2 viral loads is that they are treated as being unique to an individual laboratory. For this reason, clinical guidance based on viral loads should not cite Ct values. The RMs described were a suitable tool to determine the specific laboratory Ct for a given viral load. Furthermore, as Ct values can also vary between runs when using the same instrument, such RMs could be used as run controls to ensure reproducibility of the quantitative measurements.

26 December 2024 in Clinical Chemistry
Verified
Journal Article
Open access
SFSamreen Falak
Samreen Falak
DODenise M O’sUllivan
Denise M O’sUllivan
MCMegan H. Cleveland
Megan H. Cleveland
SCSimon Cowen
Simon Cowen
EBEloise Busby
Eloise Busby
JHJim Huggett
Jim Huggett
Background: Nucleic acid amplification tests (NAATs) assist in the diagnosis of numerous infectious diseases. They are typically sensitive and specific and can be quickly developed and adapted. Far more challenging is the development of standards to ensure NAATs are performing within specification; reference materials take time to develop and suitable reference measurement procedures (RMPs) have not been available. This study investigated digital PCR (dPCR) RMP delivery of traceability for NAAT external quality assessment (EQA). Methods: Three National Metrology Institutes (NMIs) applied reverse transcription (RT)-dPCR as a candidate RMP to estimate the RNA quantity in 32 independent severe acute respiratory syndrome coronavirus 2 materials. The results were combined to value assign the respective materials: 21 materials were used in 6 rounds of EQA over 17 months for 61 laboratories for COVID-19 testing results compared with reference values. Results: The agreement between the 3 NMIs showed <2-fold difference between laboratories. EQA laboratory reverse transcription quantitative PCR (RT-qPCR) values estimation of viral RNA quantity showed good median agreement with RT-dPCR reference value; however, RT-qPCR differences were generally between 10- and 50-fold between laboratories. Conclusion: This work demonstrates how RT-dPCR can provide reference values for whole virus materials for NAAT quality assurance. RT-dPCR values guided EQA control material selection and provided EQA participants with traceability to RNA copy number delivered through the RMP. This approach can be used to support routine reference material use as well as to standardize quality assurance for NAATs where established reference materials are not available, such as in disease outbreaks.

13 April 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ADAlison S. Devonshire
Alison S. Devonshire
EBEloise Busby
Eloise Busby
GJGerwyn M. Jones
Gerwyn M. Jones
DODenise M. O’sullivan
Denise M. O’sullivan
AFAna Fernandez-Gonzalez
Ana Fernandez-Gonzalez
JHJim Huggett
Jim Huggett
Infection with human immunodeficiency virus (HIV)-1 leads to acquired immunodeficiency syndrome (AIDS) if left untreated. According to UN figures, approximately 39 million people globally were living with HIV in 2022, with 76% of those individuals accessing antiretroviral therapy. Measurement of plasma viral RNA load using calibrated nucleic acid amplification tests (like reverse transcription quantitative PCR, RT-qPCR) is routinely performed to monitor response to treatment and ultimately prevent viral transmission. RNA quantities measured by commercial tests can vary over many orders of magnitude, from trace single copy levels to, in cases, over 10 9 /mL of plasma, presenting an analytical challenge for calibrating across a broad measurement range. Interlaboratory study CCQM-P199 “HIV-1 RNA copy number quantification” (April to September 2019) was conducted under the auspices of the Consultative Committee for Amount of Substance (CCQM) Nucleic Acid analysis Working Group (NAWG), with the aims of supporting national metrology institutes (NMIs) and designated institutes (DIs) development of the capacity and evaluating candidate reference measurement procedures for applied viral nucleic acid measurements. Thirteen laboratories participated in CCQM-P199 and were requested to report the RNA copy number concentration, expressed in copies per microliter, of the HIV-1 group specific antigen ( gag ) gene of in vitro transcribed RNA molecules at low (≈ 10 3 /μL) and high concentration (≈ 10 9 /μL) (Study Materials 1 and 2, linked by gravimetric dilution) and purified genomic RNA from cultured virus (Study Material 3). Study Materials 1 and 3 were measured by participants using one-step reverse transcription digital PCR (RT-dPCR) (Bio-Rad reagents) and/or two-step RT-dPCR with alternative cDNA synthesis reagents. Study Material 2 was measured by both RT-dPCR (one-step) ( n = 4) and orthogonal methods: single molecule flow cytometric counting ( n = 2), high performance liquid chromatograph (HPLC) ( n = 1) and isotype dilution-mass spectrometry (ID-MS) ( n = 1). Interlaboratory reproducibilities (expressed as %CV) were 21.4 %, 15.3 % and 22.0 % for Study Materials 1, 2 and 3 respectively. Analysis of overdispersion showed that the interlaboratory variation for all three Study Materials was not accounted for in their reported uncertainties, indicating uncharacterized sources of variation remain. Although the mean values of RT-dPCR and orthogonal method results were not statistically significantly different ( p = 0.46), the extrapolated mean Study Material 2 results were higher than mean Study Material 1 results (1196 vs . 808 /μL; p < 0.05). Follow-up analysis of Study Material 2 purity by ultra-performance liquid chromatography (UPLC) indicated higher molecular weight (MW) impurities constituted 16.6 % of the molecules, which are hypothesised to be the cause of the HPLC and ID-MS results being higher than the majority of Study Material 1 and 2 results. This study demonstrates that reproducible measurement of RNA templates was achieved by metrology laboratories, illustrating the potential of RT-dPCR combined with complimentary orthogonal approaches to support traceability and precision of contemporary methods for RNA quantification. This study also highlighted that detailed characterization of RNA materials and sources of bias affecting measurements such as RT efficiency is needed to further establish RT-dPCR as a primary reference measurement procedure for RNA copy number quantification.

31 March 2026 in Methods
Verified
Journal Article
Open access
SFSamreen Falak
Samreen Falak
JBJörn Beheim-Schwarzbach
Jörn Beheim-Schwarzbach
AHAlexander Hübner
Alexander Hübner
MKMartin Kammel
Martin Kammel
AMAnnemarie Martin
Annemarie Martin
EVEsmeralda Valiente
Esmeralda Valiente
Since May 2022, a wave of several thousand cases of monkeypox Virus (MPXV) infections has been reported across Europe. In the beginning of this outbreak, reference material (RM) and reference measurement procedure (RMP) were lacking. We developed a measurement procedure using digital PCR (dPCR) for the absolute quantification of the viral genome of MPXV. This study investigated dPCR as potential reference method for MPXV quantification and evaluated performance in the External quality assessment (EQA) and clinical samples. This included DNA extraction performance using two commercial kits, MPXV target assays performance in duplex format and assay characteristics to differentiate the MPXV to Orthopoxvirus (OPXV). The analytical performance and validation on different dPCR platforms were examined. The developed dPCR assay was applied and supported extensive EQA schemes for mokeypox/Orthopox virus genome detection program and assigned reference values to the corresponding EQA materials within the range of 103 copies/mL to 107 copies/mL. The candidate reference method was applied to clinical MPXV patients' samples. The estimated viral DNA quantity in clinical samples using quantitative real time PCR (qPCR) showed good correlation and agreement with dPCR reference value. Thus, the dPCR-based method enabled reliable value assignment of MPXV reference materials. This method offers a calibration-free alternative for labs without access to certified standards. Our findings suggest that dPCR could be used for reference measurement value assignment of MPXV reference materials to support calibration of MPXV viral load testing in molecular diagnostic testing laboratories.

27 March 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ADAlison S. Devonshire
Alison S. Devonshire
EBEloise Busby
Eloise Busby
GJGerwyn M. Jones
Gerwyn M. Jones
DODenise M. O’sullivan
Denise M. O’sullivan
AFAna Fernandez-Gonzalez
Ana Fernandez-Gonzalez
JHJim Huggett
Jim Huggett
Nucleic acid amplification tests including reverse transcription quantitative PCR (RT-qPCR) are used to detect RNA from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of the Coronavirus disease 2019 (COVID-19) pandemic. Standardized measurements of RNA can facilitate comparable performance of laboratory tests in the absence of existing reference measurement systems early on in a pandemic. Interlaboratory study CCQM P199b “SARS-CoV-2 RNA copy number quantification” was designed to test the fitness-for-purpose of developed candidate reference measurement procedures (RMPs) for SARS-CoV-2 genomic targets in purified RNA materials, and was conducted under the auspices of the Consultative Committee for Amount of Substance: Metrology in Chemistry and Biology (CCQM) to evaluate the measurement comparability of national metrology institutes (NMIs) and designated institutes (DIs), thereby supporting international standardization. Twenty-one laboratories participated in CCQM P199b and were requested to report the RNA copy number concentration, expressed in number of copies per microliter, of the SARS-CoV-2 nucleocapsid ( N ) gene partial region (NC_045512.2: 28274-29239) and envelope ( E ) gene (NC_045512.2: 26245-26472) (optional measurements) in samples consisting of in vitro transcribed RNA or purified RNA from lentiviral constructs. Materials were provided in two categories: lower concentration (≈ (10 1 -10 4 ) /μL in aqueous solution containing human RNA background) and high concentration (≈ 10 9 /μL in aqueous solution without any other RNA background). For the measurement of N gene concentration in the lower concentration study materials, the majority of laboratories ( n = 17) used one-step reverse transcription-digital PCR (RT-dPCR), with three laboratories applying two-step RT-dPCR and one laboratory RT-qPCR. Sixteen laboratories submitted results for E gene concentration. Reproducibility (% CV or equivalent) for RT-dPCR ranged from 19 % to 31 %. Measurements of the high concentration study material by orthogonal methods (isotope dilution-mass spectrometry and single molecule flow cytometry) and a gravimetrically linked lower concentration material were in a good agreement, suggesting a lack of overall bias in RT-dPCR measurements. However methodological factors such as primer and probe (assay) sequences, RT-dPCR reagents and dPCR partition volume were found to be potential sources of interlaboratory variation which need to be controlled when applying this technique. This study demonstrates that the accuracy of RT-dPCR is fit-for-purpose as a RMP for viral RNA target quantification in purified RNA materials and highlights where metrological approaches such as the use of in vitro transcribed controls, orthogonal methods and measurement uncertainty evaluation can support standardization of molecular methods.